PL2540723T3 - Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1 - Google Patents

Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1

Info

Publication number: PL2540723T3
Authority: PL; Poland
Prior art keywords: spirocycles; inhibitors; dehydrogenase type; steroid dehydrogenase; beta hydroxyl
Prior art date: 2007-06-21

Application number

PL12178110T

Other languages

English (en)

Inventor

Wenqing Yao

Jincong Zhuo

Colin Zhang

Original Assignee

Incyte Holdings Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-21

Filing date

2008-06-20

Publication date

2015-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39731144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2540723(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-20 Application filed by Incyte Holdings Corp filed Critical Incyte Holdings Corp

2015-07-31 Publication of PL2540723T3 publication Critical patent/PL2540723T3/pl

Links

101710088194 Dehydrogenase Proteins 0.000 title 1
-1 hydroxyl steroid Chemical class 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

PL12178110T 2007-06-21 2008-06-20 Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1 PL2540723T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94548707P	2007-06-21	2007-06-21
EP12178110.8A EP2540723B8 (en)	2007-06-21	2008-06-20	Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
EP08771573.6A EP2173750B9 (en)	2007-06-21	2008-06-20	Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1

Publications (1)

Publication Number	Publication Date
PL2540723T3 true PL2540723T3 (pl)	2015-07-31

Family

ID=39731144

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL12178110T PL2540723T3 (pl)	2007-06-21	2008-06-20	Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1
PL08771573T PL2173750T3 (pl)	2007-06-21	2008-06-20	Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL08771573T PL2173750T3 (pl)	2007-06-21	2008-06-20	Spirocykle jako inhibitory dehydrogenazy 11-beta hydroksysteroidowej typu 1

Country Status (30)

Country	Link
US (4)	US8278318B2 (pl)
EP (3)	EP2173750B9 (pl)
JP (2)	JP5364702B2 (pl)
KR (1)	KR101554471B1 (pl)
CN (1)	CN101815716B (pl)
AR (1)	AR067090A1 (pl)
AU (1)	AU2008265656B2 (pl)
BR (1)	BRPI0812904A2 (pl)
CA (1)	CA2691150C (pl)
CL (1)	CL2008001839A1 (pl)
CO (1)	CO6150151A2 (pl)
CR (1)	CR11183A (pl)
CY (2)	CY1113212T1 (pl)
DK (2)	DK2540723T3 (pl)
EA (1)	EA016017B1 (pl)
EC (1)	ECSP109844A (pl)
ES (2)	ES2390937T3 (pl)
GE (1)	GEP20135754B (pl)
HR (2)	HRP20120772T1 (pl)
IL (1)	IL202842A (pl)
MX (1)	MX2009014274A (pl)
NZ (1)	NZ582524A (pl)
PL (2)	PL2540723T3 (pl)
PT (2)	PT2540723E (pl)
RS (2)	RS52519B9 (pl)
SI (2)	SI2173750T1 (pl)
TW (1)	TWI428340B (pl)
UA (1)	UA98651C2 (pl)
WO (1)	WO2008157752A1 (pl)
ZA (1)	ZA201000233B (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI350168B (en) *	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
MXPA06014572A (es) *	2004-06-24	2007-03-12	Incyte Corp	Compuestos amido y su uso como farmaceuticos.
US20060009491A1 (en) *	2004-06-24	2006-01-12	Incyte Corporation	Amido compounds and their use as pharmaceuticals
WO2006012226A2 (en) *	2004-06-24	2006-02-02	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
EP1768954A4 (en) *	2004-06-24	2008-05-28	Incyte Corp	2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS
EA200700251A1 (ru) *	2004-08-10	2007-08-31	Инсайт Корпорейшн	Амидосоединения и их применение в качестве фармацевтических средств
US8110581B2 (en)	2004-11-10	2012-02-07	Incyte Corporation	Lactam compounds and their use as pharmaceuticals
WO2007101270A1 (en) *	2006-03-02	2007-09-07	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US8088776B2 (en)	2006-04-21	2012-01-03	Eli Lilly And Company	Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
NZ571175A (en)	2006-04-21	2011-10-28	Lilly Co Eli	Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
BRPI0710273A2 (pt)	2006-04-21	2011-08-09	Lilly Co Eli	composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, intermediário
ATE472542T1 (de)	2006-04-24	2010-07-15	Lilly Co Eli	11-beta-hydroxysteroid-dehydrogenase-1-hemmer
CA2649650C (en)	2006-04-24	2014-01-14	Eli Lilly And Company	Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
ATE543798T1 (de)	2006-04-24	2012-02-15	Lilly Co Eli	Cyclohexyl-substituierte pyrrolidinone als hemmer von 11-beta-hydroxysteroiddehydrogenase 1
US7968585B2 (en)	2006-04-25	2011-06-28	Eli Lilly And Company	Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EP2021337B1 (en)	2006-04-25	2010-01-13	Eli Lilly And Company	Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
AU2007244863B2 (en)	2006-04-25	2012-01-19	Eli Lilly And Company	Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
MX2008013844A (es)	2006-04-28	2008-11-10	Lilly Co Eli	Pirrolidinonas substituidas con pieridinilo como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1.
JP2009537564A (ja) *	2006-05-17	2009-10-29	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
CL2008001839A1 (es) *	2007-06-21	2009-01-16	Incyte Holdings Corp	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
AR074466A1 (es)	2008-12-05	2011-01-19	Sanofi Aventis	Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
US8507493B2 (en)	2009-04-20	2013-08-13	Abbvie Inc.	Amide and amidine derivatives and uses thereof
WO2011068927A2 (en) *	2009-12-04	2011-06-09	Abbott Laboratories	11-β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11B-HSD1) INHIBITORS AND USES THEREOF
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2015123424A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
LT3105218T (lt)	2014-02-13	2019-12-10	Incyte Corp	Ciklopropilaminai kaip lsd1 inhibitoriai
EP3392244A1 (en)	2014-02-13	2018-10-24	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en)	2014-02-13	2016-12-27	Incyte Corporation	Cyclopropylamines as LSD1 inhibitors
WO2016007736A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyrazines as lsd1 inhibitors
WO2016007731A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyridines and imidazopyrazines as lsd1 inhibitors
US9758523B2 (en)	2014-07-10	2017-09-12	Incyte Corporation	Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EA201792205A1 (ru)	2015-04-03	2018-02-28	Инсайт Корпорейшн	Гетероциклические соединения как ингибиторы lsd1
DK3334709T3 (da)	2015-08-12	2025-02-03	Incyte Holdings Corp	Salte af en lsd1-hæmmer
EP3235813A1 (en)	2016-04-19	2017-10-25	Cidqo 2012, S.L.	Aza-tetra-cyclo derivatives
CA3021678A1 (en)	2016-04-22	2017-10-26	Incyte Corporation	Formulations of an lsd1 inhibitor
US10435841B2 (en) *	2016-05-03	2019-10-08	GranBio Intellectual Property Holdings, LLC	Nanocellulose-reinforced corrugated medium
US10968200B2 (en)	2018-08-31	2021-04-06	Incyte Corporation	Salts of an LSD1 inhibitor and processes for preparing the same

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4439606A (en) *	1982-05-06	1984-03-27	American Cyanamid Company	Antiatherosclerotic 1-piperazinecarbonyl compounds
US5206240A (en) *	1989-12-08	1993-04-27	Merck & Co., Inc.	Nitrogen-containing spirocycles
US5852029A (en) *	1990-04-10	1998-12-22	Israel Institute For Biological Research	Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5102886A (en)	1990-10-12	1992-04-07	American Home Products Corporation	1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
DE4234295A1 (de) *	1992-10-12	1994-04-14	Thomae Gmbh Dr K	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2705343B1 (fr) *	1993-05-17	1995-07-21	Fournier Ind & Sante	Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2724656B1 (fr) *	1994-09-15	1996-12-13	Adir	Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2734265B1 (fr)	1995-05-17	1997-06-13	Adir	Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2736053B1 (fr) *	1995-06-28	1997-09-19	Sanofi Sa	Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
WO1997011940A1 (en)	1995-09-29	1997-04-03	Eli Lilly And Company	Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
WO2001030780A2 (en)	1999-10-27	2001-05-03	Cor Therapeutics, Inc.	Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
NZ519183A (en) *	1999-12-03	2005-02-25	Ono Pharmaceutical Co	Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
EP1294358B1 (en)	2000-06-28	2004-08-18	Smithkline Beecham Plc	Wet milling process
US7294637B2 (en) *	2000-09-11	2007-11-13	Sepracor, Inc.	Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
WO2003000657A1 (en) *	2001-06-20	2003-01-03	Daiichi Pharmaceutical Co., Ltd.	Diamine derivatives
US6547958B1 (en) *	2001-07-13	2003-04-15	Chevron U.S.A. Inc.	Hydrocarbon conversion using zeolite SSZ-59
GB0118238D0 (en)	2001-07-26	2001-09-19	Smithkline Beecham Plc	Medicaments
GB0126292D0 (en)	2001-11-01	2002-01-02	Smithkline Beecham Plc	Compounds
NZ533567A (en)	2001-12-28	2007-06-29	Acadia Pharm Inc	Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events
US6818772B2 (en) *	2002-02-22	2004-11-16	Abbott Laboratories	Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
GB0213715D0 (en) *	2002-06-14	2002-07-24	Syngenta Ltd	Chemical compounds
AU2002354054A1 (en) *	2002-10-18	2004-05-04	Ono Pharmaceutical Co., Ltd.	Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
WO2004058727A1 (en)	2002-12-20	2004-07-15	Bayer Pharmaceuticals Corporation	Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
WO2004056744A1 (en)	2002-12-23	2004-07-08	Janssen Pharmaceutica N.V.	Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
TW200503994A (en)	2003-01-24	2005-02-01	Novartis Ag	Organic compounds
US7205318B2 (en)	2003-03-18	2007-04-17	Bristol-Myers Squibb Company	Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
DE602004027171D1 (de)	2003-04-11	2010-06-24	High Point Pharmaceuticals Llc	Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
WO2005047286A1 (ja)	2003-11-13	2005-05-26	Ono Pharmaceutical Co., Ltd.	スピロ複素環化合物
BRPI0417687A (pt)	2003-12-19	2007-04-03	Pfizer	derivados de benzenossulfonilamino-piridin-2-ila e compostos relacionados como inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 (11-beta-hsd-1) para o tratamento de diabetes e obesidade
AU2004309419A1 (en)	2003-12-23	2005-07-14	Arena Pharmaceuticals, Inc.	Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
AU2005219438B2 (en)	2004-03-03	2011-02-17	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
WO2005108359A1 (en)	2004-05-06	2005-11-17	Pfizer Inc.	Novel compounds of proline and morpholine derivatives
TWI350168B (en)	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
WO2006012226A2 (en)	2004-06-24	2006-02-02	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
MXPA06014572A (es)	2004-06-24	2007-03-12	Incyte Corp	Compuestos amido y su uso como farmaceuticos.
EP1768954A4 (en)	2004-06-24	2008-05-28	Incyte Corp	2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS
US20060009491A1 (en)	2004-06-24	2006-01-12	Incyte Corporation	Amido compounds and their use as pharmaceuticals
MXPA06014573A (es)	2004-06-24	2007-03-12	Incyte Corp	Compuestos amido y su uso como farmaceuticos.
CA2570694A1 (en) *	2004-06-24	2006-02-02	Incyte Corporation	Amido compounds and their use as pharmaceuticals
ATE509011T1 (de)	2004-06-28	2011-05-15	Hoffmann La Roche	Pyrimidinderivate als 11beta-hsd1-inhibitoren
EA200700251A1 (ru)	2004-08-10	2007-08-31	Инсайт Корпорейшн	Амидосоединения и их применение в качестве фармацевтических средств
BRPI0515931A (pt)	2004-09-29	2008-08-12	Hoffmann La Roche	compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos
US7745427B2 (en)	2004-10-22	2010-06-29	Merck Sharp & Dohme Corp.	CGRP receptor antagonists
SG161261A1 (en) *	2004-11-10	2010-05-27	Incyte Corp	Lactam compounds and their use as pharmaceuticals
US7170437B2 (en) *	2004-11-12	2007-01-30	U-Nav Microelectronics Corporation	Two-bit offset cancelling A/D converter with improved common mode rejection and threshold sensitivity
CN101103016A (zh) *	2004-11-18	2008-01-09	因塞特公司	11-β羟基类固醇脱氢酶1型抑制剂及其使用方法
CA2594116A1 (en) *	2005-01-05	2006-07-13	Abbott Laboratories	Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
EP1866285A1 (en) *	2005-03-03	2007-12-19	F. Hoffmann-Roche AG	1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
CA2621255A1 (en) *	2005-09-21	2007-04-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
KR20080048502A (ko)	2005-09-29	2008-06-02	머크 앤드 캄파니 인코포레이티드	멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
AR057579A1 (es)	2005-11-23	2007-12-05	Merck & Co Inc	Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
EA200870019A1 (ru) *	2005-12-05	2008-12-30	Инсайт Корпорейшн	Лактамовые соединения и способы их применения
US7998959B2 (en) *	2006-01-12	2011-08-16	Incyte Corporation	Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
BRPI0707408A2 (pt) *	2006-01-31	2011-05-03	Incyte Corp	compostos de amido e seu uso como produtos farmacêuticos
WO2007101270A1 (en) *	2006-03-02	2007-09-07	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070208001A1 (en) *	2006-03-03	2007-09-06	Jincong Zhuo	Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
JP2009535420A (ja) *	2006-05-01	2009-10-01	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプ１のモジュレーターとしてのテトラ置換ウレア
JP2009537564A (ja) *	2006-05-17	2009-10-29	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
JP4959794B2 (ja)	2006-07-05	2012-06-27	エフ．ホフマン−ラロシュアーゲー	１１β−ヒドロキシステロイドデヒドロゲナーゼ１型（１１β−ＨＳＤ１）の阻害剤としてのアルキルピリダジン誘導体
AU2007312391B2 (en)	2006-10-19	2012-06-21	F. Hoffmann-La Roche Ag	Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
CL2008001839A1 (es)	2007-06-21	2009-01-16	Incyte Holdings Corp	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.

2008
- 2008-06-19 CL CL2008001839A patent/CL2008001839A1/es unknown
- 2008-06-20 KR KR1020107001434A patent/KR101554471B1/ko not_active Expired - Fee Related
- 2008-06-20 WO PCT/US2008/067637 patent/WO2008157752A1/en not_active Ceased
- 2008-06-20 EA EA201070039A patent/EA016017B1/ru unknown
- 2008-06-20 EP EP08771573.6A patent/EP2173750B9/en active Active
- 2008-06-20 PL PL12178110T patent/PL2540723T3/pl unknown
- 2008-06-20 AR ARP080102645A patent/AR067090A1/es active IP Right Grant
- 2008-06-20 RS RS20120423A patent/RS52519B9/sr unknown
- 2008-06-20 US US12/143,427 patent/US8278318B2/en active Active
- 2008-06-20 PT PT12178110T patent/PT2540723E/pt unknown
- 2008-06-20 DK DK12178110.8T patent/DK2540723T3/en active
- 2008-06-20 SI SI200830779T patent/SI2173750T1/sl unknown
- 2008-06-20 TW TW097123261A patent/TWI428340B/zh not_active IP Right Cessation
- 2008-06-20 AU AU2008265656A patent/AU2008265656B2/en not_active Ceased
- 2008-06-20 EP EP12178110.8A patent/EP2540723B8/en active Active
- 2008-06-20 JP JP2010513441A patent/JP5364702B2/ja not_active Expired - Fee Related
- 2008-06-20 NZ NZ582524A patent/NZ582524A/en unknown
- 2008-06-20 CA CA2691150A patent/CA2691150C/en active Active
- 2008-06-20 EP EP14193608.8A patent/EP2918586A1/en not_active Withdrawn
- 2008-06-20 CN CN2008801022458A patent/CN101815716B/zh not_active Expired - Fee Related
- 2008-06-20 MX MX2009014274A patent/MX2009014274A/es active IP Right Grant
- 2008-06-20 UA UAA201000514A patent/UA98651C2/ru unknown
- 2008-06-20 PT PT08771573T patent/PT2173750E/pt unknown
- 2008-06-20 ES ES08771573T patent/ES2390937T3/es active Active
- 2008-06-20 GE GEAP200811654A patent/GEP20135754B/en unknown
- 2008-06-20 HR HRP20120772AT patent/HRP20120772T1/hr unknown
- 2008-06-20 PL PL08771573T patent/PL2173750T3/pl unknown
- 2008-06-20 DK DK08771573.6T patent/DK2173750T3/da active
- 2008-06-20 SI SI200831387T patent/SI2540723T1/sl unknown
- 2008-06-20 ES ES12178110T patent/ES2531056T3/es active Active
- 2008-06-20 RS RS20150103A patent/RS53839B1/sr unknown
- 2008-06-20 BR BRPI0812904-5A2A patent/BRPI0812904A2/pt not_active Application Discontinuation
2009
- 2009-12-20 IL IL202842A patent/IL202842A/en active IP Right Grant
- 2009-12-29 CO CO09148800A patent/CO6150151A2/es unknown
2010
- 2010-01-04 CR CR11183A patent/CR11183A/es unknown
- 2010-01-05 EC EC2010009844A patent/ECSP109844A/es unknown
- 2010-01-12 ZA ZA2010/00233A patent/ZA201000233B/en unknown
2012
- 2012-09-14 US US13/619,160 patent/US9006260B2/en active Active
- 2012-10-17 CY CY20121100974T patent/CY1113212T1/el unknown
2013
- 2013-07-17 JP JP2013148780A patent/JP5730956B2/ja not_active Expired - Fee Related
2015
- 2015-02-18 CY CY20151100167T patent/CY1116029T1/el unknown
- 2015-02-19 HR HRP20150197AT patent/HRP20150197T1/hr unknown
- 2015-04-07 US US14/680,745 patent/US9371323B2/en active Active
2016
- 2016-06-10 US US15/178,838 patent/US9873698B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2691150A1 (en)	2008-12-24
TW200909431A (en)	2009-03-01
WO2008157752A1 (en)	2008-12-24
CA2691150C (en)	2015-11-24
CO6150151A2 (es)	2010-04-20
ECSP109844A (es)	2010-02-26
TWI428340B (zh)	2014-03-01
CY1113212T1 (el)	2016-04-13
US8278318B2 (en)	2012-10-02
EP2540723A1 (en)	2013-01-02
JP2014015463A (ja)	2014-01-30
US20130018068A1 (en)	2013-01-17
UA98651C2 (ru)	2012-06-11
EP2173750B9 (en)	2017-04-05
HK1180325A1 (en)	2013-10-18
US20160280708A1 (en)	2016-09-29
SI2540723T1 (sl)	2015-04-30
ES2390937T3 (es)	2012-11-19
EP2540723B8 (en)	2015-01-28
RS52519B (sr)	2013-04-30
KR101554471B1 (ko)	2015-09-30
ZA201000233B (en)	2016-08-31
JP5730956B2 (ja)	2015-06-10
PL2173750T3 (pl)	2012-12-31
EA016017B1 (ru)	2012-01-30
JP5364702B2 (ja)	2013-12-11
IL202842A0 (en)	2010-06-30
GEP20135754B (en)	2013-02-25
IL202842A (en)	2014-11-30
CN101815716A (zh)	2010-08-25
ES2531056T3 (es)	2015-03-10
NZ582524A (en)	2012-05-25
HRP20120772T1 (hr)	2012-10-31
HRP20150197T1 (en)	2015-03-27
US20080318991A1 (en)	2008-12-25
SI2173750T1 (sl)	2012-11-30
US9873698B2 (en)	2018-01-23
EP2918586A1 (en)	2015-09-16
HK1143156A1 (en)	2010-12-24
EA201070039A1 (ru)	2010-06-30
EP2540723B1 (en)	2014-11-26
AR067090A1 (es)	2009-09-30
PT2173750E (pt)	2012-10-11
PT2540723E (pt)	2015-03-06
KR20100045440A (ko)	2010-05-03
JP2010530893A (ja)	2010-09-16
RS53839B1 (sr)	2015-06-30
MX2009014274A (es)	2010-03-25
EP2173750A1 (en)	2010-04-14
DK2540723T3 (en)	2015-01-19
CN101815716B (zh)	2012-12-26
DK2173750T3 (da)	2012-11-19
BRPI0812904A2 (pt)	2014-12-09
CY1116029T1 (el)	2017-01-25
EP2173750B1 (en)	2012-08-01
CR11183A (es)	2010-02-16
AU2008265656A1 (en)	2008-12-24
US9371323B2 (en)	2016-06-21
US20150210692A1 (en)	2015-07-30
US9006260B2 (en)	2015-04-14
RS52519B9 (sr)	2020-12-31
AU2008265656B2 (en)	2014-05-29
CL2008001839A1 (es)	2009-01-16

Publication	Publication Date	Title
HRP20150197T1 (en)	2015-03-27	Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
HUS1900009I1 (hu)	2019-03-28	Új vegyületek és készítmények, továbbá alkalmazási eljárásaik
ZA201000318B (en)	2010-10-27	Inhibitors of 11b-hydroxysteroid dehydrogenase
TWI347321B (en)	2011-08-21	Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
PT2341943T (pt)	2019-02-06	Composições e métodos para a inibição específica de expressão génica por dsrna que possui modificações
IL208896A0 (en)	2011-01-31	Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
ZA200908342B (en)	2010-08-25	Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
IL195803A0 (en)	2011-08-01	Compositions and methods for sirna inhibition of angiogenesis
IL197869A0 (en)	2009-12-24	Compositions of chk1 inhibitors
PL1888582T3 (pl)	2011-05-31	Imidazo- oraz triazolopirydyny jako inhibitory dehydrogenazy 11-beta-hydroksysteroidowej typu I
PL2300461T3 (pl)	2013-09-30	Cykliczne inhibitory dehydrogenazy 11beta-hydroksysteroidów 1
SG2014014153A (en)	2014-05-29	Preventing and/or treatingmetabolic disorders by modulatingthe amount of enterobacteria
ZA200904916B (en)	2010-09-29	N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
ZA200810862B (en)	2009-12-30	Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1)
IL199941A0 (en)	2010-04-15	Compositions of stable tiacumicins
IL198807A0 (en)	2010-02-17	Compositions of azimilide dihydrochloride
ZA201008553B (en)	2011-09-28	Steroidal compounds as melanogenesis modifiers and uses thereof
EP2181192A4 (en)	2010-08-18	MODIFICATION OF THE LIGNIN BIOSYNTHESIS OVER SENSE SUPPRESSION
PL2439202T3 (pl)	2016-12-30	Inhibitory dehydrogenazy 11b-hydroksysteroidowej typu 1
IL215249A0 (en)	2011-12-29	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PL2035379T3 (pl)	2010-11-30	Inhibitory dehydrogenazy 11-beta-hydroksysteroidowej typu 1
HK1134481A (en)	2010-04-30	N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
HK1132255A (en)	2010-02-19	N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
HK1138186A (en)	2010-08-20	Methods of suppressing ltp inhibition